Search Results - "Gavura, S."

Comparative Effectiveness of FOLFIRINOX Versus Gemcitabine and Nab-paclitaxel in Initially Unresectable Locally Advanced Pancreatic Cancer: A Population-based Study to Assess Subsequent Surgical Resection and Overall Survival by Dai, W.F., Habbous, S., Saluja, R., Beca, J.M., Raphael, M., Arias, J., Gavura, S., Earle, C.C., Biagi, J.J., Coburn, N., Chan, K.K.W.

“…First-line FOLFIRINOX (FOLinic acid, Fluorouracil, IRINotecan, and OXaliplatin) and gemcitabine plus nab-paclitaxel (GnP) have been publicly funded for…”
Get full text

Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces by Beca, J.M., Dai, W.F., Pataky, R.E., Tran, D., Dvorani, E., Isaranuwatchai, W., Peacock, S., Alvi, R., Cheung, W.Y., Earle, C.C., Gavura, S., Chan, K.K.W.

“…To examine the real-world safety of adding bevacizumab to first-line irinotecan-based chemotherapy for patients with metastatic colorectal cancer (mCRC)…”
Get full text

International variability in the reimbursement of cancer drugs by publically funded drug programs by Cheema, P K, Gavura, S, Migus, M, Godman, B, Yeung, L, Trudeau, M E

“…Evaluate inter-country variability in the reimbursement of publically funded cancer drugs, and identify factors such as cost containment measures that may…”
Get full text

Impact of a novel prioritization framework on clinician-led oncology drug submissions by Keech, J, Beca, J, Eisen, A, Kennedy, E, Kim, J, Kouroukis, C T, Darling, G, Ferguson, S E, Finelli, A, Petrella, T M, Perry, J R, Chan, K, Gavura, S

“…In Canada, requests for public reimbursement of cancer drugs are predominately initiated by pharmaceutical manufacturers. Clinician-led submissions provide a…”
Get full text

Leukocytoclastic vasculitis associated with clarithromycin by Gavura, SR, Nusinowitz, S

“…OBJECTIVE: To report a possible case of leukocytoclastic vasculitis associated with clarithromycin therapy. CASE SUMMARY: An 83-year-old white woman was…”
Get full text

Global variations in reimbursement of new cancer therapeutics: Improving access through risk-sharing agreements by Cheema, P. K., Gavura, S., Godman, B., Yeung, L., Trudeau, M. E.

“…Abstract only…”
Get full text

Trends in trastuzumab utilization in Ontario: A single payer system by Trudeau, M. E., Yeung, L., Iyer, R., Hertz, S., Gavura, S., Sawka, C.

“…Abstract only…”
Get full text

Association of hospital and physician case volumes with cardiac monitoring and cardiotoxicity during adjuvant trastuzumab treatment for breast cancer: a retrospective cohort study by Chin-Yee, Nicolas J., MD, Kumachev, Alexander, MSc, Krahn, Murray, MD MSc, Yan, Andrew T., MD, Brezden-Masley, Christine, MD PhD, Ko, Dennis, MD MSc, Tomlinson, George, PhD, Trudeau, Maureen E., MD, Chan, Kelvin K.W., MD MSc, Earle, Craig, MD MSc, Krzyzanowska, Monika, MD MPH, Pal, Raveen, MD, Gavura, Scott, BScPharm MBA, Lien, Kelly, BSc

“…Abstract Background Adjuvant trastuzumab is the standard of care for patients with HER2 overexpressing breast cancer, but use of trastuzumab may lead to…”
Get full text

Relationship between financial indicators in the Slovak engineering industry: A panel regression approach by Jencova, Sylvia, Petruška, Igor, Gavura, Štefan, Miskufova, Marta, Bačík, Radovan

“…The aim of this article is to analyse the relationship between financial indicators in the Slovak engineering industry. We analyse the dependence of the…”
Get full text

Hyperkalemia associated with spironolactone therapy by Dolovich, Lisa, Gavura, Scott, Pottie, Kevin

Get full text